AKT1 and cancer: Consequently, this hinders the aggressive nature of melanoma cells and prompts their programmed cell death.[37] Furthermore, luteolin up-regulate MLL3, an epigenetic regulator and tumor suppressor that is commonly altered in human cancers, inhibiting the Ras gene and subsequently inactivating the PI3K/AKT/mTOR pathway.